Table 1.
Body weights, FBG and HbA1c values from the Swiss Webster mice
| Week | Treatment | FBG (mg/dl) | Weight (g) | (n) | HbA1c (%) | (n) |
|---|---|---|---|---|---|---|
| Week 12 |
Veh |
112 ± 21 |
37.2 ± 5.4 |
10 |
5.0 ± 0.4 |
6 |
| STZ |
595 ± 12* |
30.6 ± 3.7* |
11 |
12.9 ± 0.2* |
7 |
|
| Week 21 |
Veh + Veh |
121 ± 26 |
42.6 ± 5.4 |
8 |
5.1 ± 0.1 |
3 |
| Veh + Erl |
104 ± 17 |
43.4 ± 2.7 |
8 |
5.0 ± 0.2 |
3 |
|
| STZ + Veh |
545 ± 106* |
34.5 ± 3.5* |
8 |
10.2 ± 1.7* |
4 |
|
| STZ + Erl | 584 ± 40# | 37.0 ± 5.5# | 6 | 11.4 ± 1.1# | 4 |
*, p < 0.05 vs. Veh or Veh + Veh; #, p < 0.05 vs. Veh + Erlotinib (Erl).